Abstract
BackgroundQuality and duration of response to rituximab in RF/CCP-positive RA is variable. Higher pre-and post-treatment plasmablasts are associated with non/short-response. The objective of this study was to assess the relationship...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
